Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proof-of-Concept, CASAD for Treatment of Clostridium Difficile Infection

NCT01570634 is registered in ClinicalTrials.gov with Salient Pharmaceuticals Incorporated as lead sponsor.

NCT NCT01570634
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01570634 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proof-of-Concept, CASAD for Treatment of Clostridium Difficile Infection
Lead sponsor
Salient Pharmaceuticals Incorporated
Phase
Phase 2
Overall status
Terminated
Start date
March 31, 2012
Completion date
September 30, 2012
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diarrhoea, clostridium difficile